A debilitating autoimmune condition silently attacks the spine and surrounding joints, causing inflammation that gradually transforms flexible vertebrae into rigid, fused bone. Ankylosing spondylitis ... At first glance, it might seem like inflammatory bowel disease (IBD) and ankylosing spondylitis (AS) don’t have much in common.

Understanding the Context

But despite their different areas of focus, these two conditions ... Morning back pain can signal more than just back muscle stiffness. A new review suggests that whole body cryotherapy could be the answer to address ankylosing spondylitis. Tumor necrosis factor inhibitors may offer mental health benefits in the management of patients with ankylosing spondylitis.

Key Insights

The American Journal of Managed Care: Bimekizumab Shows Long-Term Efficacy in Nonradiographic AxSpA, Ankylosing Spondylitis Bimekizumab demonstrated safety and efficacy at 2 years among patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS). Bimekizumab is currently FDA approved ... Healio: ‘Surprising and good’: Bimekizumab shows strong 5-year efficacy in ankylosing spondylitis Whole-body cryotherapy significantly improves pain, function, and disease activity in ankylosing spondylitis. Read more.